Viral Vectors

Due to their complex structure and size, as well as a constantly evolving regulatory landscape, the physico-chemical and biological characterisation of viral vector-based products is challenging.

With extensive experience in the analysis of innovative products and thanks to a continuous investment in new technologies and machinery, Quality Assistance can assist you in the development of your recombinant Adeno-Associated Viral Vectors (rAAVs) products from early phases to commercialisation.